Company Search:
Advanced Search
Sponsored Links
Zoetis Inc Company Snapshot
Zoetis Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zoetis Inc with three other companies in this sector in UNITED STATES : Alexion Pharmaceuticals, Inc. (2020 sales of $6.07 billion of which 67% was Soliris), Perrigo Company PLC ($5.06 billion of which 53% was CSCA), and Vertex Pharmaceuticals Inc ($6.21 billion of which 62% was TRIKAFTA).

Sales Analysis. During the second quarter of 2021, sales at Zoetis Inc totalled $1.95 billion. This is an increase of 25.8% from the $1.55 billion in sales at the company during the second quarter of 2020. This was the biggest same quarter rise in sales at Zoetis Inc in the previous 35 quarters. During the first two quarters of 2021, sales totalled $3.82 billion, which is 23.9% higher than through the first two quarters of 2020. During the previous 22 quarters, sales at Zoetis Inc have increased compared with the same quarter in the previous year. Sales at Zoetis Inc appear to have some seasonality: during each of the previous 9 years, sales have been highest during the fourth quarter, which has accounted for between 26.1% and 27.6% of the annual sales. During the year ended December of 2020, sales at Zoetis Inc were $6.68 billion. This is an increase of 6.6% versus 2019, when the company's sales were $6.26 billion. This was the fifth consecutive year of sales increases at Zoetis Inc (and since 2015, sales have increased a total of 40%). Sales of International saw an increase of 2.1% in 2020, from $2.97 billion to $3.04 billion. Not all segments of Zoetis Inc experienced an increase in sales in 2020: sales of Contract Manufacturing fell 2.4% to $83.00 million. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Zoetis Inc
  Stock Performance Chart for Zoetis Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/22/2021): 208.51
(Figures in U.S. Dollars)
1 Week 3.1%   13 Weeks 1.8%  
4 Weeks 2.4%   52 Weeks 27.5%  
Zoetis Inc Key Data:
  Ticker: ZTS Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 6,675,000,000
(Year Ending Jan 2021).
Employees: 11,300
  Currency: U.S. Dollars Market Cap: 98,877,700,163
  Fiscal Yr Ends: December Shares Outstanding: 474,210,830
  Share Type: Class A Common Closely Held Shares: 951,707
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.